Cargando…
Reduction of Experimental Cerebral Malaria and Its Related Proinflammatory Responses by the Novel Liposome-Based β-Methasone Nanodrug
Cerebral malaria (CM) is a severe complication of and a leading cause of death due to Plasmodium falciparum infection. CM is likely the result of interrelated events, including mechanical obstruction due to parasite sequestration in the microvasculature, and upregulation of Th1 immune responses. In...
Autores principales: | Guo, Jintao, Waknine-Grinberg, Judith H., Mitchell, Andrew J., Barenholz, Yechezkel, Golenser, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121993/ https://www.ncbi.nlm.nih.gov/pubmed/25126550 http://dx.doi.org/10.1155/2014/292471 |
Ejemplares similares
-
Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria
por: Waknine-Grinberg, Judith H., et al.
Publicado: (2013) -
Artemisone effective against murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010) -
Schistosoma mansoni infection reduces the incidence of murine cerebral malaria
por: Waknine-Grinberg, Judith H, et al.
Publicado: (2010) -
Indocyanine Green Liposomes for Diagnosis and Therapeutic Monitoring of Cerebral Malaria
por: Portnoy, Emma, et al.
Publicado: (2016) -
Controlled release of artemisone for the treatment of experimental cerebral malaria
por: Golenser, Jacob, et al.
Publicado: (2017)